Press "Enter" to skip to content

New patent expiration for Novartis drug DIOVAN HCT


Annual Drug Patent Expirations for DIOVAN+HCT
Annual Drug Patent Expirations for DIOVAN+HCT

Diovan Hct is a drug marketed by Novartis
and is included in one NDA. It is available from nine suppliers. There is one patent protecting this drug and two Paragraph IV challenges.

The generic ingredient in DIOVAN HCT is hydrochlorothiazide; valsartan. Nine suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; valsartan profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
or visit

Do NOT follow this link or you will be banned from the site!